Phenotyping of IgG4-related diseases based on affected organ pattern: A multicenter cohort study using cluster analysis

References

• Stone JH, Zen Y, Deshpande V. IG4-related disease. N Engl J Med. 2012;366(6):539–51.
   PubMed Web of Science ®Google Scholar
• Inoue D, Yoshida K, Yoneda N, Ozaki K, Matsubara T, Nagai K, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015;94(15):e680.
   PubMed Web of Science ®Google Scholar
• Kanno A, Masamune A, Okazaki K, Kamisawa T, Kawa S, Nishimori I, et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011. Pancreas 2015;44(4):535–9.
   PubMed Web of Science ®Google Scholar
• Hert PA, Kamisawa T, Brugge WR, Chung JB, Culver EL, Czakó L, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2013;62:1771–6.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Yajima H, Takahashi H, Yokoyama Y, Ishigami K, Shimizu Y, et al. Everyday clinical practice in IgG4-related dacryoadenitis and/or sialadenitis: results from the SMART database. Mod Rheumatol. 2015;25(2):199–204.
   PubMed Web of Science ®Google Scholar
• Della Torre E, Mattoo H, Mahajan VS, Carruthers M, Pillai S, Stone JH. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy 2014;69(2):269–72.
   PubMed Web of Science ®Google Scholar
• Schupp JC, Freitag-Wolf S, Bargagli E, Mihailović-Vučinić V, Rottoli P, Grubanovic A, et al. Phenotypes of organ involvement in sarcoidosis. Eur Respir J. 2018;51(1):1700991.
   PubMed Web of Science ®Google Scholar
• Adegunsoye A, Oldham JM, Chung JH, Montner SM, Lee C, Witt LJ, et al. Phenotypic clusters predict outcomes in a longitudinal lung disease cohort. Chest 2018;153(2):349–60.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Takano K, Kamekura R, Suzuki C, Tabeya T, Murakami R, et al. Predicting therapeutic response in IgG4-related disease based on cluster analysis. Immunol Med. 2018;41(1):30–3.
   PubMedGoogle Scholar
• Wallace ZS, Zhang Y, Perugino C, Naden R, Choi HK, Stone JH. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 2019;78(3):406–12.
   PubMed Web of Science ®Google Scholar
• Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnosis criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22(1):21–30.
   PubMed Web of Science ®Google Scholar
• Matsui S, Yamamoto H, Minamoto S, Waseda Y, Mishima M, Kubo K. Proposed diagnosis criteria for IgG4-related respiratory disease. Respir Investig. 2016;54(2):130–2.
   PubMed Web of Science ®Google Scholar
• Shirakashi M, Yoshifuji H, Kodama Y, Chiba T, Yamamoto M, Takahashi H, et al. Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study. Sci Rep. 2018;8(1):10262.
   PubMedGoogle Scholar
• Handa T, Matsui S, Yoshifuji H, Kodama Y, Yamamoto H, Minamoto S, et al. Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease. Mod Rheumatol 2018;28:828–44.
   Web of Science ®Google Scholar
• Shiokawa M, Kodama Y, Yoshimura K, Mimura J, Yamashita Y, Asada M, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol. 2013;108(4):610–7.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Takahashi H, Tabeya T, Suzuki C, Naishiro Y, Ishigami K, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012;22(3):414–8.
   PubMed Web of Science ®Google Scholar
• Hirano K, Tada M, Sasahira N, Isayama H, Mizuno S, Takagi K, et al. Incidence of malignancies in patients with IgG4-related disease. Intern Med. 2014;53(3):171–6.
   PubMed Web of Science ®Google Scholar
• Hart PA, Law RJ, Dierkhising RA, Smyrk TC, Takahashi N, Chari ST. Risk of cancer in autoimmune pancreatitis: a case-control study and review of the literature. Pancreas 2014;43(3):417–21.
   PubMed Web of Science ®Google Scholar
• Huggett MT, Culver EL, Kumar M, Hurst JM, Rodriguez-Justo M, Chapman MH, et al. Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am J Gastroenterol. 2014;109(10):1675–83.
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Ramsey-Goldman R, Clarke A. Malignancy and autoimmunity. Curr Opin Rheumatol. 2006;18(2):129–34.
   PubMed Web of Science ®Google Scholar
• Szekanecz Z, Szekanecz E, Bakó G, Shoenfeld Y. Malignancies in autoimmune rheumatic diseases – a mini-review. Gerontology 2011;57(1):3–10.
   PubMed Web of Science ®Google Scholar
• Sigurgeirsson B, Lindelóf B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med. 1992;326(6):363–7.
   PubMed Web of Science ®Google Scholar
• Shiokawa M, Kodama Y, Sekiguchi K, Kuwada T, Tomono T, Kuriyama K, et al. Laminin 511 is a target antigen in autoimmune pancreatitis. Sci Transl Med. 2018;10(453):eaaq0997.
   PubMed Web of Science ®Google Scholar
• Saeki T, Kobayashi D, Ito T, Tamura M, Yoshikawa S, Yamazaki H. Comparison of clinical and laboratory features of patients with and without allergic conditions in IgG4-related disease: a single-center experience in Japan. Mod Rheumatol. 2018;28(5):845–8.
   PubMed Web of Science ®Google Scholar
• Tanaka A, Moriyama M, Nakashima H, Miyake K, Hayashida J-N, Maehara T, et al. Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease. Arthritis Rheum. 2012;64(1):254–63.
   PubMed Web of Science ®Google Scholar
• Handa T, Matsui S, Yoshifuji H, Kodama Y, Yamamoto H, Minamoto S, et al. Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease. Mod Rheumatol. 2018;28(5):838–44.
   PubMed Web of Science ®Google Scholar
• Matsui S, Hebisawa A, Sakai F, Yamamoto H, Terasaki Y, Kurihara Y, et al. Immunoglobulin G4-related lung disease: clinicoradiological and pathological features. Respirology 2013;18(3):480–7.
   PubMed Web of Science ®Google Scholar
• Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol. 2015;67(9):2466–75.
   PubMed Web of Science ®Google Scholar
• Yamada K, Yamamoto M, Saeki T, Mizushima I, Matsui S, Fujisawa Y, et al. New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases. Arthritis Res Ther. 2017;19(1):262.
   PubMedGoogle Scholar
• Matsui S. IgG4-related respiratory disease. Mod Rheumatol. 2019;29(2):251–6.
   PubMed Web of Science ®Google Scholar